Medical Journals

Tobacco Smoking, Nat2 Acetylation Genotype and Breast Cancer Risk.

Authors:
  • Lissowska Jolanta
  • Brinton Louise A
  • Zatonski Witold
  • Blair Aaron
  • Bardin-Mikolajczak Alicja
  • Peplonska Beata
  • Sherman Mark E
  • Szeszenia-Dabrowska Neonila
  • Chanock Stephen
  • GarcĂ­a-Closas Montserrat

From: Department of Cancer Epidemiology and Prevention, Cancer Center and M. Sklodowska-Curie Institute of Oncology, Warsaw, Poland. lissowsj@coi.waw.pl

International journal of cancer. Journal international du cancer

  • Publish Date: Oct 2006
  • ISSN: 0020-7136
  • Volume: 119
  • Issue: 8
  • Pages: 1961-9
  • Medium: Print
  • Language: English
  • Citation (JAMA): Lissowska Jolanta, Brinton Louise A, Zatonski Witold, et al. Tobacco Smoking, Nat2 Acetylation Genotype and Breast Cancer Risk.. Int. J. Cancer Oct 2006;119:1961-9

Abstract

The role of active and passive cigarette smoking in breast cancer etiology remains controversial. Using data from a large population-based case-control study in Poland (2386 cases, 2502 controls) conducted during 2000-2003, we examined the associations between active and passive smoking overall and for different age categories. We also evaluated differences in risk by estrogen receptor (ER) and progesterone receptor (PR) status in tumors, and the potential modification of the smoking association by N-acetyl transferase 2 (NAT2) genotype. Women ever exposed to passive smoking at home or at work had a risk of breast cancer similar to those never exposed to active or passive smoking (OR (95%CI) = 1.11 (0.85-1.46), and no trends were observed with increasing hours/day-years of passive smoking exposure. Active smoking was associated with a significant increase in risk only among women younger than 45 years of age (OR (95%CI) = 1.95 (1.38-2.76); 1.15 (0.93-1.40); 0.91 (0.77-1.09) for < 45, 45-55 and > 55 years of age, respectively; p-heterogeneity < 0.001 for < 45 vs. > 55 years) and prevailed for both ER+ and ER- tumors. The smoking association among women < 45 years was stronger for current than former smokers, and a significant trend was observed with duration of smoking (p = 0.04). NAT2 slow vs. rapid/intermediate acetylation genotype was not related to breast cancer risk (0.99 (0.87-1.13)), and did not significantly modify the smoking relationships. In conclusion, our data indicate that passive smoking is not associated with breast cancer risk; however, active smoking might be associated with an increased risk for early onset breast cancers.

Mesh Headings (Keywords): Acetylation, Adult, Age Distribution, Aged, Arylamine N-Acetyltransferase, Breast Neoplasms, Female, Genotype, Humans, Middle Aged, Receptors, Estrogen, Receptors, Progesterone, Risk Factors, Smoking


Check for Full Text / PubMed Unique Identifier (PMID): 16721725


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.